|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH PAPER
1 Department of Molecular and Human Genetics, 2 Bone Disease Program of Texas, Baylor College of Medicine, Houston, Texas 77030, USA; 3 The Burnham Institute, La Jolla, California 92037, USA; 4 Faculty of Dentistry and Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada H3A 2B2
Extracellular matrix (ECM) mineralization is a physiological process in bone and a pathological one in soft tissues. The mechanisms determining the spatial restriction of ECM mineralization to bone physiologically are poorly understood. Here we show that a normal extracellular phosphate concentration is required for bone mineralization, while lowering this concentration prevents mineralization of any ECM. However, simply raising extracellular phosphate concentration is not sufficient to induce pathological mineralization, this is because of the presence in all ECMs of pyrophosphate, an inhibitor of mineralization. ECM mineralization occurs only in bone because of the exclusive coexpression in osteoblasts of Type I collagen and Tnap, an enzyme that cleaves pyrophosphate. This dual requirement explains why Tnap ectopic expression in cells producing fibrillar collagen is sufficient to induce pathological mineralization. This study reveals that coexpression in osteoblasts of otherwise broadly expressed genes is necessary and sufficient to induce bone mineralization and provides evidence that pathological mineralization can be prevented by modulating extracellular phosphate concentration.
[Keywords: ECM; mineralization; TNAP; pyrophosphate; collagen]
Received October 25, 2004; revised version accepted March 14, 2005.
Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1276205.
E-MAIL karsenty{at}bcm.tmc.edu; FAX (713) 798-1465.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N.R. Kaipatur, M. Murshed, and M.D. McKee Matrix Gla Protein Inhibition of Tooth Mineralization J. Dent. Res., September 1, 2008; 87(9): 839 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, J. Zhou, W. Tang, R. Menard, J. Q. Feng, and L. D. Quarles Pathogenic role of Fgf23 in Dmp1-null mice Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E254 - E261. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Johnson, M. Polewski, and R. A. Terkeltaub Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle Cells Circ. Res., March 14, 2008; 102(5): 529 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Moe and N. X. Chen Mechanisms of Vascular Calcification in Chronic Kidney Disease J. Am. Soc. Nephrol., February 1, 2008; 19(2): 213 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Johnson, W. Yao, N. E. Lane, P. Naquet, and R. A. Terkeltaub Vanin-1 Pantetheinase Drives Increased Chondrogenic Potential of Mesenchymal Precursors in ank/ank Mice Am. J. Pathol., February 1, 2008; 172(2): 440 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, J. Zhu, P. Valverde, L. Li, S. Pageau, Q. Tu, R. Nishimura, T. Yoneda, P. Yang, W. Zheng, et al. Phenotypic Analysis of Dlx5 Overexpression in Post-natal Bone J. Dent. Res., January 1, 2008; 87(1): 45 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Phan, O. Ivanovski, I. G. Nikolov, N. Joki, J. Maizel, L. Louvet, M. Chasseraud, T. Nguyen-Khoa, B. Lacour, T. B. Drueke, et al. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure Nephrol. Dial. Transplant., January 1, 2008; 23(1): 82 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ketteler and P. Biggar After several years of witchhunting, can calcium-based phosphate binding be released on probation? Nephrol. Dial. Transplant., January 1, 2008; 23(1): 17 - 19. [Full Text] [PDF] |
||||
![]() |
S. Liu, W. Tang, J. Zhou, L. Vierthaler, and L. D. Quarles Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1636 - E1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Huffman, J. A. Keightley, C. Chaoying, R. J. Midura, D. Lovitch, P. A. Veno, S. L. Dallas, and J. P. Gorski Association of Specific Proteolytic Processing of Bone Sialoprotein and Bone Acidic Glycoprotein-75 with Mineralization within Biomineralization Foci J. Biol. Chem., September 7, 2007; 282(36): 26002 - 26013. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Cahill, D. Wenkert, S. A. Perlman, A. Steele, S. P. Coburn, W. H. McAlister, S. Mumm, and M. P. Whyte Infantile Hypophosphatasia: Transplantation Therapy Trial Using Bone Fragments and Cultured Osteoblasts J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2923 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Stubbs, S. Liu, W. Tang, J. Zhou, Y. Wang, X. Yao, and L. D. Quarles Role of Hyperphosphatemia and 1,25-Dihydroxyvitamin D in Vascular Calcification and Mortality in Fibroblastic Growth Factor 23 Null Mice J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2116 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. N. Addison, F. Azari, E. S. Sorensen, M. T. Kaartinen, and M. D. McKee Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity J. Biol. Chem., May 25, 2007; 282(21): 15872 - 15883. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, P. S N Rowe, L. Vierthaler, J. Zhou, and L D. Quarles Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity J. Endocrinol., January 1, 2007; 192(1): 261 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, J. Zhou, W. Tang, X. Jiang, D. W. Rowe, and L. D. Quarles Pathogenic role of Fgf23 in Hyp mice Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E38 - E49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Shao, J. Cai, and D. A. Towler Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1423 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ketteler, G. Schlieper, and J. Floege Calcification and Cardiovascular Health: New Insights Into an Old Phenomenon Hypertension, June 1, 2006; 47(6): 1027 - 1034. [Full Text] [PDF] |
||||
![]() |
N. Matsuo, S. Tanaka, M. K. Gordon, M. Koch, H. Yoshioka, and F. Ramirez CREB-AP1 Protein Complexes Regulate Transcription of the Collagen XXIV Gene (Col24a1) in Osteoblasts J. Biol. Chem., March 3, 2006; 281(9): 5445 - 5452. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schipani, A. Zallone, G. J. Strewler, J. W. Pike, S. Ferrari, Y. Jiang, and E. Seeman Meeting Report from the 27th Annual Meeting of the American Society for Bone and Mineral Research: September 23-27, 2005 in Nashville, Tennessee, USA IBMS BoneKEy, January 1, 2006; 3(1): 29 - 62. [Full Text] [PDF] |
||||
![]() |
M. J. Glimcher Bone: Nature of the Calcium Phosphate Crystals and Cellular, Structural, and Physical Chemical Mechanisms in Their Formation Reviews in Mineralogy and Geochemistry, January 1, 2006; 64(1): 223 - 282. [Full Text] [PDF] |
||||
![]() |
M. Ketteler and J. Floege Calcification and the usual suspect phosphate: still guilty but there are other guys behind the scenes Nephrol. Dial. Transplant., January 1, 2006; 21(1): 33 - 35. [Full Text] [PDF] |
||||
![]() |
R. A. Deckelbaum, A. Majithia, T. Booker, J. E. Henderson, and C. A. Loomis The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling Development, January 1, 2006; 133(1): 63 - 74. [Abstract] [Full Text] [PDF] |
||||